Journal of the American College of Cardiology

Papers
(The H4-Index of Journal of the American College of Cardiology is 111. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–20194569
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up2111
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic1281
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic881
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease854
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure817
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19730
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction595
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization567
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary539
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection522
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement522
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research442
The Global Burden of Cardiovascular Diseases and Risk405
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy370
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19358
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation349
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain344
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary334
Preeclampsia—Pathophysiology and Clinical Presentations313
Cardiac Troponin for Assessment of Myocardial Injury in COVID-19309
Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations304
Worldwide Prevalence of Familial Hypercholesterolemia303
Characterization of Myocardial Injury in Patients With COVID-19288
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic286
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction280
The Global Burden of Cardiovascular Diseases and Risks274
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes273
Virtual Learning During the COVID-19 Pandemic268
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation250
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic248
Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease248
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care241
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19225
SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies222
2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Pl222
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases218
Spontaneous Coronary Artery Dissection217
Management of Acute Myocardial Infarction During the COVID-19 Pandemic215
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease215
Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality212
Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy212
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction210
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk205
Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation204
The ARIC (Atherosclerosis Risk In Communities) Study200
Machine Learning and the Future of Cardiovascular Care197
Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy194
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants193
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis191
Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation182
Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States180
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women175
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction174
Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis174
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy171
Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China168
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves166
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy164
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease164
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk162
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk161
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia160
Heart Failure With Recovered Left Ventricular Ejection Fraction155
Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis154
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary154
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary152
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19152
Cardiovascular Deaths During the COVID-19 Pandemic in the United States151
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients149
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia147
Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation147
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI145
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients144
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19144
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or Wi143
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement140
Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies139
Management of Hypertrophic Cardiomyopathy134
Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy133
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis132
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease131
Pathophysiology of Takotsubo Syndrome131
2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation130
International Impact of COVID-19 on the Diagnosis of Heart Disease130
Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis129
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study128
Interventions for Frailty Among Older Adults With Cardiovascular Disease127
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque126
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy125
Presentation and Outcome of Arrhythmic Mitral Valve Prolapse122
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial122
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction121
Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S.121
Challenges in Cardiac and Pulmonary Sarcoidosis119
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation119
Cardiac Involvement in Fabry Disease119
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure118
Inflammation, Aging, and Cardiovascular Disease118
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System118
Ticagrelor With or Without Aspirin After Complex PCI117
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial116
Global Chronic Total Occlusion Crossing Algorithm116
Prevalence and Prognostic Significance of Malnutrition in Patients With Acute Coronary Syndrome116
Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease114
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury113
Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction113
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis113
Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality112
Medial Arterial Calcification112
Smartphone Activation of Citizen Responders to Facilitate Defibrillation in Out-of-Hospital Cardiac Arrest112
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial111
0.039546966552734